BEXCELLENT GP (01775) plans to issue 25.38 million shares with a premium of approximately 20.48%, raising approximately HK$12.57 million net.
Elite Group (01775) announced that on August 18, 2025, the company plans to subscribe to the subscriber Mr. Dong Baoyou (T...
BEXCELLENT GP (01775) announces that on August 18, 2025, the company intends to issue a total of 25.38 million subscription shares to subscriber Po-yu TUNG, which is equivalent to approximately 4.76% of the total number of issued shares after the issuance of the subscription shares. The subscription price for each subscription share is HK$0.50, representing a premium of approximately 20.48% over the closing price of HK$0.415 on August 18.
The estimated net proceeds from the issuance of subscription shares is approximately HK$12.57 million. The company plans to use the net proceeds from the subscription for the following purposes to support the growth and operational improvements of the group: 30% for upgrading the infrastructure and technology of the teaching center, introducing advanced solutions such as artificial intelligence tools and systems to enhance the learning platform, assessment tools, and management systems; 30% for recruiting high-level teaching professionals and experts, conducting training and development programs, focusing on innovative teaching methods to strengthen and expand the teaching team; 10% for promoting brand development and visibility through advertising and publicity activities; and 30% as working capital to support daily operations.
Related Articles

HATCHER GROUP (08365) signs partnership agreement with EF HongKong and EF Commodities and may make equity investments in Esperanza.

GAPACK (00468) will distribute a final dividend of HK$0.22 per share on September 30th.

KONTA CHINA (01312): Tongfang Pharmaceuticals and Beijing Qingkong signed a construction contract in Beijing with a capital investment of approximately 33.67 million yuan.
HATCHER GROUP (08365) signs partnership agreement with EF HongKong and EF Commodities and may make equity investments in Esperanza.

GAPACK (00468) will distribute a final dividend of HK$0.22 per share on September 30th.

KONTA CHINA (01312): Tongfang Pharmaceuticals and Beijing Qingkong signed a construction contract in Beijing with a capital investment of approximately 33.67 million yuan.

RECOMMEND

Former Innovative Pharma Star Faces Growing Pains—Why Zai Lab’s Stock Tumbled Despite Strong Results
18/08/2025

World Humanoid Robot Games In-Depth: Competition Drives Technological Innovation and Accelerates Industry Progress
18/08/2025

Guangdong Cross-Border E-Commerce: Tariff Pressures Spur Overseas Warehouse Boom as Sellers Target Russia and Latin America
18/08/2025